Clinical Trial 49951

Pomonca, CA 91767


The Purpose of this study is to access the safty and immune response or mRNA-1345 and mRNA vaccine targeting RSV when given alone or coadministered with SARS-CoV-2 vaccine in health older adults.

Study details include:

  • The Study duration will be up for 7 months 
  • The treatment is 2 injections
  • The visit frequency will be 3 visits inthe frist month.


To be Qualified in RSV & Covid study please see the requirments.

  • Age 50 and older
  • Fully Vaccinated for COVID-19 with an approved primary seies accprding to yhr locally authorized or approved regimen.If te most recent COVID-19 vaccine was part of a primary series, it must be 150 days before Day 1 .If the most recent COVID-19 vaccine was a booster dose, it must be 120 days before day 1.
  • If you are a Female participants have to be on contraception for 3 months while being on the study.
  • Able to comply with study requirments, including access to transportation for study visits

Qualified Participants May Receive:

Payment for this is study is $ 1,230

Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.